These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9563167)

  • 1. The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.
    Sanyal PK
    Vet Res Commun; 1998 Feb; 22(2):87-96. PubMed ID: 9563167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative disposition kinetics of albendazole in sheep following oral and intraruminal administration.
    Swarnkar CP; Sanyal PK; Singh D; Khan FA; Bhagwan PS
    Vet Res Commun; 1998 Dec; 22(8):545-51. PubMed ID: 10066128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ricobendazole in calves.
    Formentini EA; Mestorino ON; Mariño EL; Errecalde JO
    J Vet Pharmacol Ther; 2001 Jun; 24(3):199-202. PubMed ID: 11442798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single and divided dose administration on the pharmacokinetics of albendazole in sheep and goat.
    Sanyal PK
    Vet J; 1998 May; 155(3):311-6. PubMed ID: 9638078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves.
    Sánchez SF; Alvarez LI; Lanusse CE
    J Vet Pharmacol Ther; 1997 Feb; 20(1):38-47. PubMed ID: 9049948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition kinetics of albendazole in buffalo and cattle.
    Sanyal PK
    J Vet Pharmacol Ther; 1997 Jun; 20(3):240-2. PubMed ID: 9185092
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.
    Formentini EA; Mestorino N; Errecalde JO
    Vet Res Commun; 2005 Oct; 29(7):595-608. PubMed ID: 16142607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    J Vet Pharmacol Ther; 1999 Apr; 22(2):77-86. PubMed ID: 10372592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.
    Capece BP; Castells G; Pérez F; Arboix M; Cristòfol C
    Vet Res Commun; 2000 Jul; 24(5):339-48. PubMed ID: 10868551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
    Goudah A
    Vet Res Commun; 2003 Oct; 27(7):555-66. PubMed ID: 14609267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of diet type and pretreatment fasting on the disposition kinetics of albendazole in sheep.
    Singh D; Sanyal PK; Swarnkar CP; Khan FA; Bhagwan PS
    Vet Res Commun; 1999 Jun; 23(4):229-40. PubMed ID: 10461800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition kinetics of albendazole and metabolites in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic disposition of triclabendazole in buffalo compared to cattle.
    Sanyal PK
    J Vet Pharmacol Ther; 1995 Oct; 18(5):370-4. PubMed ID: 8587156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolite concentrations in plasma following treatment of cattle with five anthelmintics.
    Prichard RK; Hennessy DR; Steel JW; Lacey E
    Res Vet Sci; 1985 Sep; 39(2):173-8. PubMed ID: 4070784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
    Lanchote VL; Garcia FS; Dreossi SA; Takayanagui OM
    Ther Drug Monit; 2002 Jun; 24(3):338-45. PubMed ID: 12021623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
    Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography.
    Sarin R; Dash AP; Dua VK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(2):233-8. PubMed ID: 14670741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics and bioavailability of albendazole sulfoxide in sheep and goats, and dose-dependent plasma disposition in goats.
    Aksit D; Yalinkilinc HS; Sekkin S; Boyacioğlu M; Cirak VY; Ayaz E; Gokbulut C
    BMC Vet Res; 2015 May; 11():124. PubMed ID: 26012791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in the disposition of albendazole metabolites in sheep.
    Cristòfol C; Navarro M; Franquelo C; Valladares JE; Arboix M
    Vet Parasitol; 1998 Aug; 78(3):223-31. PubMed ID: 9760064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.